Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?

F Medioli, E Bacca, M Faltoni, GJ Burastero, S Volpi… - Antibiotics, 2022 - mdpi.com
Background: Despite the global efforts to antagonize carbapenem-resistant Acinetobacter
baumannii (CRAB) spreading, it remains an emerging threat with a related mortality …

Ceftazidime/avibactam in ventilator-associated pneumonia due to difficult-to-treat non-fermenter Gram-negative bacteria in COVID-19 patients: a case series and …

…, E Franceschini, A Bedini, A Cervo, M Faltoni… - Antibiotics, 2022 - mdpi.com
Ventilator-associated pneumonia (VAP) in critically ill patients with COVID-19 represents a
very huge global threat due to a higher incidence rate compared to non-COVID-19 patients …

Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID‐19 patients with pneumonia

…, L Gozzi, D Jaacoub, M Faltoni… - European Journal of …, 2020 - Wiley Online Library
Studies on the interactions between SARS‐CoV‐2 and humoral immunity are fundamental
to elaborate effective therapies including vaccines. We used polychromatic flow cytometry, …

Hypokalemia in patients with COVID-19

…, F Piccinini, G Franceschi, S Volpi, M Faltoni… - Clinical and …, 2021 - Springer
Background Patients with COVID-19 experience multiple clinical conditions that may cause
electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated …

Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—challenges, strengths, and opportunities in a global health emergency

…, R Tonelli, F Ghinelli, M Meschiari, S Volpi, M Faltoni… - PLoS …, 2020 - journals.plos.org
Aims The aim of this study was to estimate a 48 hour prediction of moderate to severe
respiratory failure, requiring mechanical ventilation, in hospitalized patients with COVID-19 …

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections

M Meschiari, S Volpi, M Faltoni, G Dolci… - JAC-Antimicrobial …, 2021 - academic.oup.com
Objectives To describe our real-life experience with cefiderocol in XDR and difficult-to-treat
resistant Pseudomonas aeruginosa (DTR-P) infections without any other available treatment …

A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients

…, R Scutari, GJ Burastero, S Volpi, M Faltoni… - Communications …, 2022 - nature.com
Little is known about SARS-CoV-2 evolution under Molnupiravir and Paxlovid, the only
antivirals approved for COVID-19 treatment. By investigating SARS-CoV-2 variability in 8 …

COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion

…, R Tonelli, G Alfano, S Volpi, M Faltoni… - …, 2020 - academic.oup.com
SIR, Thrombosis in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection represents the most relevant extra-pulmonary manifestation of COVID-19 and …

[HTML][HTML] Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator

…, G Ciusa, L Corradi, M Di Gaetano, M Faltoni… - Clinical Microbiology …, 2021 - Elsevier
Objectives Sex differences in COVID-19 severity and mortality have been described. Key
aims of this analysis were to compare the risk of invasive mechanical ventilation (IMV) and …

Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life …

M Meschiari, M Faltoni, S Kaleci, G Tassoni… - International Journal of …, 2024 - Elsevier
Aim To investigate the efficacy of intravenous (IV) fosfomycin as combination therapy for
treatment of difficult-to-treat (DTT) acute and subacute infections with multi-drug-resistant (MDR) …